1
|
OUP accepted manuscript. Lab Med 2022; 53:349-359. [DOI: 10.1093/labmed/lmac005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
2
|
Cadamuro J, Hillarp A, Unger A, von Meyer A, Bauçà JM, Plekhanova O, Linko-Parvinen A, Watine J, Leichtle A, Buchta C, Haschke-Becher E, Eisl C, Winzer J, Kristoffersen AH. Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group "postanalytical phase" (WG-POST). Crit Rev Clin Lab Sci 2021; 58:329-353. [PMID: 33538219 DOI: 10.1080/10408363.2020.1867051] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
In laboratory medicine, much effort has been put into analytical quality in the past decades, making this medical profession one of the most standardized with the lowest rates of error. However, even the best analytical quality cannot compensate for errors or low quality in the pre or postanalytical phase of the total testing process. Guidelines for data reporting focus solely on defined data elements, which have to be provided alongside the analytical test results. No guidelines on how to format laboratory reports exist. The habit of reporting as much diagnostic data as possible, including supplemental information, may lead to an information overload. Considering the multiple tasks physicians have to do simultaneously, unfiltered data presentation may contribute to patient risk, as important information may be overlooked, or juxtaposition errors may occur. As laboratories should aim to answer clinical questions, rather than providing sole analytical results, optimizing formatting options may help improve the effectiveness and efficiency of medical decision-making. In this narrative review, we focus on the underappreciated topic of laboratory result reporting. We present published literature, focusing on the impact of laboratory result report formatting on medical decisions as well as approaches, potential benefits, and limitations for alternative report formats. We discuss influencing variables such as, for example, the type of patient (e.g. acute versus chronic), the medical specialty of the recipient of the report, the display of reference intervals, the medium or platform on which the laboratory report is presented (printed paper, within electronic health record systems, on handheld devices, etc.), the context in which the report is viewed in, and difficulties in formatting single versus cumulative reports. Evidence on this topic, especially experimental studies, is scarce. When considering the medical impact, it is of utmost importance that laboratories focus not only on the analytical aspects but on the total testing process. The achievement of high analytical quality may be of minor value if essential results get lost in overload or scattering of information by using a non-formatted tabular design. More experimental studies to define guidelines and to standardize effective and efficient reporting are most definitely needed.
Collapse
Affiliation(s)
- Janne Cadamuro
- Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
| | - Andreas Hillarp
- Department of Clinical Chemistry, Halland Hospital, Halmstad, Sweden
| | | | - Alexander von Meyer
- Institute for Laboratory Medicine and Medical Microbiology, Medizet, München-Klinik, Munich, Germany
| | - Josep Miquel Bauçà
- Department of Laboratory Medicine, Hospital Universitari Son Espases, Palma, Spain
| | - Olga Plekhanova
- Laboratory Diagnostics Center, State Clinical Hospital No. 67 named after L.A. Vorokhobov Moscow Healthcare Department, Moscow, Russia
| | - Anna Linko-Parvinen
- Laboratory of Haematology, Tykslab, Laboratory Division, Turku University Hospital, Turku, Finland
| | - Joseph Watine
- Laboratoire de Biologie Médicale, Hôpital de Villefranche-de-Rouergue, France
| | - Alexander Leichtle
- University Institute of Clinical Chemistry, Inselspital - Bern University Hospital and University of Bern, Bern, Switzerland
| | - Christoph Buchta
- Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA), Vienna, Austria
| | | | - Christoph Eisl
- School of Business & Management, University of Applied Sciences Upper Austria, Steyr, Austria
| | - Johannes Winzer
- School of Business & Management, University of Applied Sciences Upper Austria, Steyr, Austria
| | - Ann Helen Kristoffersen
- Department of Medical Biochemistry and Pharmacology, Laboratory Clinic, Haukeland University Hospital and Noklus, Haraldsplass Deaconess Hospital, Bergen, Norway
| |
Collapse
|
3
|
Morley JF, Cohen A, Silveira-Moriyama L, Lees AJ, Williams DR, Katzenschlager R, Hawkes C, Shtraks JP, Weintraub D, Doty RL, Duda JE. Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test. NPJ PARKINSONS DISEASE 2018; 4:2. [PMID: 29354684 PMCID: PMC5768805 DOI: 10.1038/s41531-017-0039-8] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/10/2017] [Revised: 12/08/2017] [Accepted: 12/13/2017] [Indexed: 11/09/2022]
Abstract
The 40-item University of Pennsylvania Smell Identification Test (UPSIT) is an effective instrument to detect olfactory dusfunction in Parkinson's disease (PD). It is not clear, however, whether tests of this length are necessary to detect such dysfunction. Several studies have suggested that detection of certain odors is selectively compromised in PD, and that a test comprised of these odors could be shorter and more specific for this purpose. Therefore, we attempted to identify a subset of UPSIT odors that distinguish PD from controls with similar or improved test characteristics compared to the full test. The discriminatory power of each odor was examined using UPSIT data from a discovery cohort of 314 PD patients and 314 matched controls and ranked using multiple methods (including odds ratios, regression coefficients and discriminant analysis). To validate optimally discriminant subsets, we calculated test characteristics using data from two independent cohorts (totaling 306 PD and 343 controls). In the discovery cohort, multiple novel 12-item subsets (and the previously described Brief Smell Identification Test-B) performed similarly or improved upon the UPSIT and were better than 12 random items. However, in validation studies from independent cohorts, multiple subsets retained test characteristics similar to the full UPSIT, but did not outperform 12 random items. Differential discriminatory power of individual items is not conserved across independent cohorts arguing against selective hyposmia in PD. However, multiple 12-item subsets performed as well as the full UPSIT. These subsets could form the basis for shorter olfactory tests in the clinical evaluation of Parkinsonism.
Collapse
Affiliation(s)
- James F Morley
- 1Parkinson's Disease Research Education, Clinical and Education Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA USA.,2Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| | - Abigail Cohen
- 3CCEB, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| | | | - Andrew J Lees
- 6UCL Institute of Neurology, Monash University, Melbourne, VIC Australia
| | - David R Williams
- 7Department of Medicine, Monash University, Melbourne, VIC Australia
| | - Regina Katzenschlager
- 8Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Medical University of Vienna, Vienna, Austria
| | | | - Julie P Shtraks
- 1Parkinson's Disease Research Education, Clinical and Education Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA USA
| | - Daniel Weintraub
- 1Parkinson's Disease Research Education, Clinical and Education Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA USA.,2Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.,4Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| | - Richard L Doty
- 5Smell and Taste Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| | - John E Duda
- 1Parkinson's Disease Research Education, Clinical and Education Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA USA.,2Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| |
Collapse
|
4
|
Smith DH, Schneider J, Thorp ML, Vupputuri S, Weiss JW, Johnson ES, Feldstein A, Petrik AF, Yang X, Snyder SR. Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative study. BMC Nephrol 2012; 13:154. [PMID: 23173944 PMCID: PMC3537573 DOI: 10.1186/1471-2369-13-154] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2012] [Accepted: 10/28/2012] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND There is a growing awareness in primary care of the importance of identifying patients with chronic kidney disease (CKD) so that they can receive appropriate clinical care; one method that has been widely embraced is the use of automated reporting of estimated glomerular filtration rate (eGFR) by clinical laboratories. We undertook a qualitative study to examine how clinicians use eGFR in clinical decision making, patient communication issues, barriers to use of eGFR, and suggestions to improve the clinical usefulness of eGFR reports. METHODS Our study used qualitative methods with structured interviews among primary care clinicians including both physicians and allied health providers, recruited from Kaiser Permanente Northwest, a non-profit health maintenance organization. RESULTS We found that clinicians generally held favorable views toward eGFR reporting but did not use eGFR to replace serum creatinine in their clinical decision-making. Clinicians used eGFR as a tool to help identify CKD, educate patients about their kidney function and make treatment decisions. Barriers noted by several clinicians included a desire for greater education regarding care for patients with CKD and tools to facilitate discussion of eGFR findings with patients. CONCLUSIONS The manner in which clinicians use eGFRs appears to be more complex than previously understood, and our study illustrates some of the efforts that might be usefully undertaken (e.g. specific clinician education) when encouraging further promulgation of eGFR reporting and usage.
Collapse
Affiliation(s)
- David H Smith
- The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Torsvik T, Lillebo B, Mikkelsen G. Presentation of clinical laboratory results: an experimental comparison of four visualization techniques. J Am Med Inform Assoc 2012; 20:325-31. [PMID: 23043123 PMCID: PMC3638193 DOI: 10.1136/amiajnl-2012-001147] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Objective To evaluate how clinical chemistry test results were assessed by volunteers when presented with four different visualization techniques. Materials and methods A total of 20 medical students reviewed quantitative test results from 4 patients using 4 different visualization techniques in a balanced, crossover experiment. The laboratory data represented relevant patient categories, including simple, emergency, chronic and complex patients. Participants answered questions about trend, overall levels and covariation of test results. Answers and assessment times were recorded and participants were interviewed on their preference of visualization technique. Results Assessment of results and the time used varied between visualization techniques. With sparklines and relative multigraphs participants made faster assessments. With relative multigraphs participants identified more covarying test results. With absolute multigraphs participants found more trends. With sparklines participants more often assessed laboratory results to be within reference ranges. Different visualization techniques were preferred for the four different patient categories. No participant preferred absolute multigraphs for any patient. Discussion Assessments of clinical chemistry test results were influenced by how they were presented. Importantly though, this association depended on the complexity of the result sets, and none of the visualization techniques appeared to be ideal in all settings. Conclusions Sparklines and relative multigraphs seem to be favorable techniques for presenting complex long-term clinical chemistry test results, while tables seem to suffice for simpler result sets.
Collapse
Affiliation(s)
- Torbjørn Torsvik
- Norwegian EPR Research Centre, Department of Neuroscience, The Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
| | | | | |
Collapse
|
6
|
Mepham SO, Squire SB, Chisuwo L, Kandulu J, Bates I. Utilisation of laboratory services by health workers in a district hospital in Malawi. J Clin Pathol 2010; 62:935-8. [PMID: 19783724 DOI: 10.1136/jcp.2009.069062] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AIMS To identify priorities for improving effective use of laboratory services in a district hospital in Malawi. METHODS A prospective observational study of clinician-patient interactions to analyse laboratory test requesting practices and utilisation of laboratory results. The proportion of tests that was appropriately ordered, processed and ultimately influenced clinical management was used to assess effectiveness of utilisation. RESULTS 420 clinical consultations between health professionals and patients were observed. 92% of tests were ordered appropriately, 84% were processed by the laboratory and 64% of results influenced patient management. 73-79% of high-volume tests (haemoglobin, microscopy for malaria and tuberculosis) and 32% of low-volume tests influenced management. CONCLUSIONS 25% of commonly requested laboratory tests were not utilised effectively; because of the high volume, interventions to improve their use are likely to be cost effective. Although 68% of low-volume tests were not used efficiently, the cost of providing support for these tests in a resource-poor setting needs to be balanced against their clinical usefulness. In contrast to published information, this study shows significant under-requesting of laboratory tests that were available. Measures to increase appropriate test requests will have implications for clinician education as well as laboratory space, budgets and staffing levels.
Collapse
Affiliation(s)
- S O Mepham
- Africa Centre for Health and Population Studies, University of KwaZulu Natal, Durban, South Africa
| | | | | | | | | |
Collapse
|
7
|
Biosca C, Ricós C, Lauzurica R, Petersen PH. Biological variation at long-term renal post-transplantation. Clin Chim Acta 2006; 368:188-91. [PMID: 16458873 DOI: 10.1016/j.cca.2005.12.018] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2005] [Revised: 12/16/2005] [Accepted: 12/16/2005] [Indexed: 12/01/2022]
Abstract
In laboratory testing the reference change value (RCV) is used to detect changes in a patient's clinical status, even before clinical signs are evident. In a previous study we determined the biological variation (BV) of a number of constituents during early post-transplantation in kidney recipients to calculate useful RCVs for this purpose. RCVs for creatinine and urate were identified as the most suitable and were different from those calculated from the normal population. The aim of the current study was to determine the BV components at long-term following renal transplantation to predict potential crises in transplant recipients who have been stable for a number of years. BV components for creatinine and urate were calculated in a new group of 40 kidney transplanted patients (26 men and 14 women, 29-71 years old) who had been stable for period of 4 to 7 years following transplantation (long-term post-TR group). An average of 8 samples per patient was obtained during a period of 1-2 years. Results were compared with those from our described group of recently transplanted patients (short-term post-TR group). There were no statistically significant differences between the groups with regard to within-subject variation or within-subject plus analytical variation (CVI+A) for any of the constituents studied. Distribution of CVI+A values in long-term post-TR was comparable to that of short-term post-TR values. Independence between creatinine and urate was maintained at long-term. The fact that BV components for creatinine and urate were similar in short- and long-term post-TR and that independence was maintained implies that the short-term post-TR RCV can also be applied in long-term post-TR patients. The RCV for predicting crises in this population represents an optimization of laboratory reporting and could be a valuable tool for clinical decision making.
Collapse
Affiliation(s)
- Carmen Biosca
- Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
| | | | | | | |
Collapse
|
8
|
Abstract
Laboratory medicine lacks the tools necessary to define appropriate test use; nonetheless, existing laboratory test characteristics, although inadequate, provide a common starting point for developing definitions of appropriate test use. As Lundberg [1], Szczepura [15], and van Walraven and Naylor [2] have emphasized, developing a process for defining appropriate laboratory use should receive a high priority. There is a particular need to develop methods for standardizing studies [59]. Laboratory medicine does not, however, lack the tools necessary to change test use. Although past interventions were largely ineffective, there is growing evidence that test use can be changed by use of a variety of approaches. By using the existing tools there is much that can be done to change inappropriate test use, such as minimizing redundant testing or the use of tests that have no clinical relevance. The real opportunities will come when there are scientifically and medically sound definitions of appropriate test use that can be used to change test use and improve patient care in a cost-effective way.
Collapse
Affiliation(s)
- Michael L Wilson
- Department of Pathology and Laboratory Services, Denver Health Medical Center, Department of Pathology, University of Colorado School of Medicine, Denver, CO, USA.
| |
Collapse
|
9
|
Scott IA, Greenberg PB, Phillips PA. The value of evidence-based medicine to consultant physicians. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 2000; 30:683-92. [PMID: 11198576 DOI: 10.1111/j.1445-5994.2000.tb04363.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- I A Scott
- Internal Medicine, Princess Alexandra Hospital, Brisbane, Qld.
| | | | | |
Collapse
|
10
|
Abstract
The current health care environment of cost-cutting highlights the need to reinforce the contribution of laboratory medicine to improvement in health care. This must be a patient-focused activity using continuous quality improvement, a familiar concept in laboratory practice. Involvement in the creation of clinical practice guidelines, care maps, and outcome measures will place laboratory medicine in the circle of continuous quality improvement. The laboratory must provide strong evidence that tests contribute to better overall resource utilization. Laboratory Information Systems can be used to better integrate laboratory data with clinical, diagnostic, pharmaceutic, statistical, and financial information. Improving laboratory utilization requires clear demonstrations of appropriate versus inappropriate laboratory use, and instructions on implementing appropriate use. The education of laboratory professionals should include search strategies, understanding the diagnostic accuracy of medical tests, and the application of systematic reviews and meta-analysis. With the rapid increase in the data base supporting evidence-based laboratory medicine, there is a significant challenge in translating the existing knowledge into practice. There is also a need for a cooperative strategy between the diagnostics industry and the laboratory medicine profession to provide evidence of the added value of laboratory testing. There is a significant role in developing the academic basis of the unique aspects of evidence-based laboratory medicine.
Collapse
Affiliation(s)
- M J McQueen
- McMaster University, Department of Pathology & Molecular Medicine, Hamilton, Ontario, Canada
| |
Collapse
|
11
|
Abstract
The National Health Service in the United Kingdom was created in 1948, effectively becoming the main provider of healthcare and funded by the government from taxation. By the late 1970's, and despite many achievements, it was seen to be approaching a financial crisis. Radical reforms were introduced in the early 1990's bringing in general management, a split between purchaser and provider, and competition. Whilst there has been a change of government more recently several of these initiatives have been retained, with the exception of competition (the internal market) which has been abandoned. There is now a much greater focus on the quality of care with increased clinical and financial accountability. Laboratory medicine (generally termed pathology in the United Kingdom) has evolved to meet the demands of more patients, reducing turnaround times, a greater repertoire of investigations and a continuing improvement in productivity. There is an increasing focus on improved dialogue between the laboratory and the clinician covering interpretation of results, audit of services and outcomes, research and development and continuous education in the pursuit of a high quality service. The major challenges for the future focus on alternative modes of delivery, on issues relating to staffing and on quality of service, in the face of an ever increasing demand.
Collapse
Affiliation(s)
- C P Price
- Department of Clinical Biochemistry, St Bartholomew's and the Royal London School of Medicine and Dentistry, Turner Street, London, UK
| | | |
Collapse
|
12
|
|
13
|
Fraser CG. Judgement of analytical quality requirements from published clinical vignette studies is flawed. Clin Chem Lab Med 1999; 37:167-8. [PMID: 10219507 DOI: 10.1515/cclm.1999.030] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|